Ain KB - Search Results

1

Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro.

Mitsiades CS, McMillin D, Kotoula V, Poulaki V, McMullan C, Negri J, Fanourakis G, Tseleni-Balafouta S, Ain KB, Mitsiades N. Mitsiades CS, et al. Among authors: ain kb. J Clin Endocrinol Metab. 2006 Oct;91(10):4013-21. doi: 10.1210/jc.2005-2472. Epub 2006 Jul 18. J Clin Endocrinol Metab. 2006. PMID: 16849420

2

Effects of p53-expressing adenovirus on the chemosensitivity and differentiation of anaplastic thyroid cancer cells.

Blagosklonny MV, Giannakakou P, Wojtowicz M, Romanova LY, Ain KB, Bates SE, Fojo T. Blagosklonny MV, et al. Among authors: ain kb. J Clin Endocrinol Metab. 1998 Jul;83(7):2516-22. doi: 10.1210/jcem.83.7.4984. J Clin Endocrinol Metab. 1998. PMID: 9661637

3

Imatinib mesylate (gleevec; STI571) monotherapy is ineffective in suppressing human anaplastic thyroid carcinoma cell growth in vitro.

Dziba JM, Ain KB. Dziba JM, et al. Among authors: ain kb. J Clin Endocrinol Metab. 2004 May;89(5):2127-35. doi: 10.1210/jc.2003-031734. J Clin Endocrinol Metab. 2004. PMID: 15126530

4

Somatostatin analogs affect proliferation of human thyroid carcinoma cell lines in vitro.

Ain KB, Taylor KD. Ain KB, et al. J Clin Endocrinol Metab. 1994 May;78(5):1097-102. doi: 10.1210/jcem.78.5.7909817. J Clin Endocrinol Metab. 1994. PMID: 7909817

5

Antineoplastic activity of taxol against human anaplastic thyroid carcinoma cell lines in vitro and in vivo.

Ain KB, Tofiq S, Taylor KD. Ain KB, et al. J Clin Endocrinol Metab. 1996 Oct;81(10):3650-3. doi: 10.1210/jcem.81.10.8855817. J Clin Endocrinol Metab. 1996. PMID: 8855817

6

Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines.

Ain KB, Taylor KD, Tofiq S, Venkataraman G. Ain KB, et al. J Clin Endocrinol Metab. 1997 Jun;82(6):1857-62. doi: 10.1210/jcem.82.6.4013. J Clin Endocrinol Metab. 1997. PMID: 9177396

7

Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na+/I-symporter gene methylation status.

Venkataraman GM, Yatin M, Marcinek R, Ain KB. Venkataraman GM, et al. Among authors: ain kb. J Clin Endocrinol Metab. 1999 Jul;84(7):2449-57. doi: 10.1210/jcem.84.7.5815. J Clin Endocrinol Metab. 1999. PMID: 10404820

8

Protein synthesis inhibitors, in synergy with 5-azacytidine, restore sodium/iodide symporter gene expression in human thyroid adenoma cell line, KAK-1, suggesting trans-active transcriptional repressor.

Li W, Venkataraman GM, Ain KB. Li W, et al. Among authors: ain kb. J Clin Endocrinol Metab. 2007 Mar;92(3):1080-7. doi: 10.1210/jc.2006-2106. Epub 2006 Dec 12. J Clin Endocrinol Metab. 2007. PMID: 17164311

9

Butyrate alters the expression and activity of cell cycle components in anaplastic thyroid carcinoma cells.

Greenberg VL, Williams JM, Boghaert E, Mendenhall M, Ain KB, Zimmer SG. Greenberg VL, et al. Among authors: ain kb. Thyroid. 2001 Jan;11(1):21-9. doi: 10.1089/10507250150500621. Thyroid. 2001. PMID: 11272092

10

Management of undifferentiated thyroid cancer.

Ain KB. Ain KB. Baillieres Best Pract Res Clin Endocrinol Metab. 2000 Dec;14(4):615-29. doi: 10.1053/beem.2000.0106. Baillieres Best Pract Res Clin Endocrinol Metab. 2000. PMID: 11289738 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters